Catalog No.
RHE01201
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
IP: 1:100-1:200
Target
STX2C, STX2B, STX2A, Syntaxin-2, Epimorphin, STX2, EPIM
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P32856
Applications
IP
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3J41
Isolation of Shiga toxin-producing Escherichia coli O157 and non-O157 from retail imported frozen beef marketed in Saudi Arabia using immunomagnetic separation and multiplex PCR., PMID:40271089
Development of ELISA Using Phage-Displayed Stx2 Mini-Body for Detection of STEC Antigen in Field Farming Pig Samples., PMID:40005748
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome., PMID:39871175
Serogroups and Toxin Variants of Clinical Shiga Toxin-Producing Escherichia coli Strains Isolated from Patients with Hemolytic Uremic Syndrome in Turkey., PMID:39728667
Molecular Evolutionary Analyses of Shiga toxin type 2 subunit A Gene in the Enterohemorrhagic Escherichia coli (EHEC)., PMID:39338486
Detection of Shiga toxin-producing Escherichia coli in dairy cows: genetic characterization and inhibition of adherence by cattle anti-STEC antibodies to HEp-2 cell., PMID:39331343
Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy., PMID:39104521
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab')2 fragments in healthy volunteers., PMID:38288879
Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies., PMID:38011121
Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage., PMID:35811684
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives., PMID:35223548
Seropositivity to Shiga toxin 2 among Argentinian urban and rural residents. Association with sociodemographic and exposure factors., PMID:34969078
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody., PMID:34822608
Development of a homogeneous time-resolved FRET (HTRF) assay for the quantification of Shiga toxin 2 produced by E. coli., PMID:34395095
Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes., PMID:33685676
Rapid and quantitative detection of Shiga toxin1 and Shiga toxin2 based on multiple targets UPT-LF assay., PMID:33204236
Comparative analysis of rapid agglutination latex test using single-chain antibody fragments (scFv) versus the gold standard Vero cell assay for Shiga toxin (Stx) detection., PMID:32497660
Zebrafish embryo sensitivity test as in vivo platform to anti-Shiga toxin compound screening., PMID:32449119
Rapid and Label-Free Immunosensing of Shiga Toxin Subtypes with Surface Plasmon Resonance Imaging., PMID:32357576
Platelet thrombus formation in eHUS is prevented by anti-MBL2., PMID:31881024
Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples., PMID:31826960
Rapid detection of Shiga toxin type II using lateral flow immunochromatography test strips of colorimetry and fluorimetry., PMID:31748765
Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice., PMID:31607541
Involvement of high mobility group box 1 in the pathogenesis of severe hemolytic uremic syndrome in a murine model., PMID:31482731
Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay., PMID:31438570
Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae., PMID:31344276
Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity., PMID:31240960
Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein., PMID:31202906
Cellular and Mucosal Immune Responses Following Vaccination with Inactivated Mutant of Escherichia coli O157:H7., PMID:31024031
Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro., PMID:30670557
Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo., PMID:30513821
Detection of Shiga Toxin 2 Produced by Escherichia coli in Foods Using a Novel AlphaLISA., PMID:30360508
Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2., PMID:30329068
Anti-inflammatory agents reduce microglial response, demyelinating process and neuronal toxin uptake in a model of encephalopathy produced by Shiga Toxin 2., PMID:30314914
Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7., PMID:29807709
[Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome]., PMID:29659360
Decreased STEC shedding by cattle following passive and active vaccination based on recombinant Escherichia coli Shiga toxoids., PMID:29514704
Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment., PMID:29494518
Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity., PMID:29483033
Structural Changes in Stx1 Engineering Monoclonal Antibody Improves Its Functionality as Diagnostic Tool for a Rapid Latex Agglutination Test., PMID:31544861
Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producing Escherichia coli strains by a time-resolved fluorescence immunoassay., PMID:29350441
Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome., PMID:29280264
Microbiological and serological control of Escherichia coli O157: H7 in kindergarten staff in Buenos Aires city and suburban areas., PMID:28643674
Antibodies to Shiga toxins in Brazilian cattle., PMID:28454739
Baicalin Protects Mice from Lethal Infection by Enterohemorrhagic Escherichia coli., PMID:28337193
Bovine Leukemia Virus and Mycobacterium avium subsp. paratuberculosis Are Not Associated with Shiga Toxin-Producing Escherichia coli Shedding in Cattle., PMID:28221870
Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model., PMID:28134751
Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7., PMID:28046078
A proteomics assay to detect eight CBRN-relevant toxins in food., PMID:28008711
Active Shiga-Like Toxin Produced by Some Aeromonas spp., Isolated in Mexico City., PMID:27725813
For research use only. Not for human or drug use.
